(Q42495039)

1 November 2017

title

Regional and intralesional treatment of invasive basal cell carcinoma with interferon alfa-n2b (English)

1 reference

1 November 2017

P A DiLorenzo

1

1 reference

1 November 2017

N Goodman

series ordinal

2

1 reference

1 November 2017

F Lansville

series ordinal

3

1 reference

1 November 2017

W Markel

series ordinal

4

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 July 1994

1 reference

Journal of the American Academy of Dermatology

1 November 2017

published in

1 reference

1 November 2017

volume

31

1 reference

1 November 2017

issue

1

1 reference

1 November 2017

page(s)

109-111

1 reference

Application of human leucocyte interferon in patients with carcinoma of the uterine cervix

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2809%2980237-5

7 January 2021

Intralesional interferon-alpha therapy in advanced malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2809%2980237-5

7 January 2021

The physiological interferon response

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2809%2980237-5

7 January 2021

Alpha-interferon in superficial bladder cancer: a Northern California Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2809%2980237-5

7 January 2021

Treatment of aggressive basal cell carcinoma with intralesional interferon: Evaluation of efficacy by Mohs surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2809%2980237-5

7 January 2021

Intralesional interferon alfa-2b in the treatment of basal cell carcinoma. Immunohistochemical study on cellular immune reaction leading to tumor regression.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2809%2980237-5

7 January 2021

Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2809%2980237-5

7 January 2021

Intralesional interferon therapy for basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2809%2980237-5

7 January 2021

Treatment of basal cell carcinoma with intralesional interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2809%2980237-5

7 January 2021

Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2809%2980237-5

7 January 2021

10.1016/S0190-9622(09)80237-5

Identifiers

DOI

1 reference

1 November 2017

1 reference